US 12188020
Methods for reducing Ataxin-2 expression
granted A61KA61K31/7088A61P
Quick answer
US patent 12188020 (Methods for reducing Ataxin-2 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 45
- CPC classes
- A61K, A61K31/7088, A61P, A61P25/28